Follow-on Offering

Healthcare
Follow-on Offering

Summary

Baird served as lead manager on the offering

About

NanoString Technologies, Inc. (“NanoString” or “the Company”) (NASDAQ:NSTG) recently completed an underwritten public offering of 5,750,000 shares of its common stock at a price to the public of $40.00 per share, including the underwriters’ option to purchase an additional 750,000 shares of common stock. The gross proceeds to NanoString from the offering are expected to be approximately $230.0 million before deducting the underwriting discounts and commissions. The transaction was upsized from the previously announced offering size of $150.0 million of common stock.

NanoString Technologies, Inc. engages in the development and commercialization of instrument and services for profiling of genes and proteins from tissue samples. NanoString offers GeoMx Digital Spatial Profiler, nCounter Systems, analysis solutions, gene expression panels, Vantage 3D Assays, miRNA Assays, custom solutions and Sample Prep and nCounter Consumables. The Company was founded on June 20, 2003 and is headquartered in Seattle, Washington.
CONTACT US TO LEARN MORE
Healthcare
Follow-on Offering
Date
October 2020
Company
NanoString Technologies, Inc.
Transaction
M&A
Sectors
Healthcare
Target Location
North America

Share